Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial

This study aims to evaluate the efficacy of vonoprazan combined with different antibiotics in dual therapy for Helicobacter pylori eradication treatment. Newly infected patients were randomly assigned to four groups: amoxicillin dual therapy, tetracycline dual therapy, minocycline dual therapy, and bismuth quadruple therapy. At the follow - up visit in the 6th week, urea breath test, rapid urease test, or Helicobacter pylori fecal antigen test will be conducted to confirm eradication.

Trial Details

NCT ID
NCT07068607
Phase
PHASE4
Sponsor
Yongquan Shi
Status
RECRUITING
Cancer Type
Gastric Cancer
Interventions
  • Vonoprazan
  • Tetracycline 500mg tid
  • Minocycline
  • Bismuth
  • Clarithromycin 500 mg
  • Amoxicillin
Locations (sample)
  • Xi'an, Shaanxi, China|34.25833,108.92861

Key Eligibility Criteria

  • Aged 18 - 70 years, regardless of gender;
  • Patients with definite Hp infection (positive result in any one of the 13C/14C urea breath test, rapid urease test, and fecal Hp antigen test) who …
  • For women of child - bearing age, it is required to use medically acceptable contraceptive methods during the trial period and within 30 days after…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →